Home › Funds › BERNZOTT CAPITAL ADVISORS › ENOV

BERNZOTT CAPITAL ADVISORS position in ENOV

ENOVIS CORPORATION · Health Care

BERNZOTT CAPITAL ADVISORS reported holding 230,128 shares of ENOV (ENOVIS CORPORATION) in its Q2 2025 13F filing — a position valued at US$7.2M, representing 3.68% of its reported portfolio and ranking #8 among its reported holdings. BERNZOTT CAPITAL ADVISORS has disclosed ENOV holdings in 8 of the last 8 reported quarters, going back to Q3 2023.

Latest position (Q2 2025)230.13K sh
Reported value held$7.22M
Portfolio Weight3.68%
First reportedQ3 2023
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How BERNZOTT CAPITAL ADVISORS's ENOV position evolved

BERNZOTT CAPITAL ADVISORS first disclosed a stake in ENOV in Q3 2023 at 72,905 shares (US$3.8M). The position peaked in Q2 2025 at 230,128 shares, worth US$7.2M. Across 8 filings, BERNZOTT CAPITAL ADVISORS increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2025) shows 230,128 shares valued at US$7.2M — an increase of 71,953 shares quarter over quarter.. Notable position changes include a 76% trim in Q1 2024 (shares fell 28% over the following quarter), a 682% increase in Q2 2024 (shares fell 5% over the following quarter), a 45% increase in Q2 2025 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 72.91K $3.84M New
Q4 2023 61.62K $3.45M Reduce
Q1 2024 14.92K $931.75K Reduce
Q2 2024 116.73K $5.28M Add
Q3 2024 139.86K $6.02M Add
Q4 2024 139.81K $6.13M Hold
Q1 2025 158.18K $6.04M Add
Q2 2025 230.13K $7.22M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENOV and 13F data

ENOV (ENOVIS CORPORATION) is a Health Care company. 19 other funds we track also report a position in ENOV — the largest reported positions include Rubric Capital Management LP (US$80.7M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PARADIGM CAPITAL MANAGEMENT INC/NY (US$28.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENOV

All ENOV fund holders →

FAQ

How long has BERNZOTT CAPITAL ADVISORS held ENOV?

BERNZOTT CAPITAL ADVISORS has disclosed ENOV holdings in 8 of the last 8 reported quarters, going back to Q3 2023.

What is BERNZOTT CAPITAL ADVISORS's current position in ENOV?

As of Q2 2025, BERNZOTT CAPITAL ADVISORS holds 230.13K shares of ENOV (ENOVIS CORPORATION), valued at $7.22M, representing 3.68% of its reported portfolio and ranking #8.

Has BERNZOTT CAPITAL ADVISORS been buying or selling ENOV?

In the latest 13F filing (Q2 2025), BERNZOTT CAPITAL ADVISORS increased its position in ENOV. The position peaked in Q2 2025 at 230.13K shares.

Which other funds hold ENOV?

Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PARADIGM CAPITAL MANAGEMENT INC/NY, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.